Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to 0.94.

  • Envoy Medical's Equity Ratio rose 5254.43% to 0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94, marking a year-over-year increase of 5254.43%. This contributed to the annual value of 1.63 for FY2024, which is 66052.15% down from last year.
  • Latest data reveals that Envoy Medical reported Equity Ratio of 0.94 as of Q3 2025, which was up 5254.43% from 3.02 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Equity Ratio ranged from a high of 0.23 in Q3 2023 and a low of 14.16 during Q4 2022
  • For the 4-year period, Envoy Medical's Equity Ratio averaged around 1.93, with its median value being 1.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Equity Ratio was 65622.77% (2023), while the steepest drop was 189058.37% (2023).
  • Quarter analysis of 4 years shows Envoy Medical's Equity Ratio stood at 14.16 in 2022, then soared by 98.48% to 0.21 in 2023, then tumbled by 660.52% to 1.63 in 2024, then skyrocketed by 42.66% to 0.94 in 2025.
  • Its Equity Ratio stands at 0.94 for Q3 2025, versus 3.02 for Q2 2025 and 2.33 for Q1 2025.